Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/11/25 19:00 | 2/7/25 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | James Andrea S. | CA | O | CFO | 1 | P | 200 | 2.05 | 0 | 98 | 182 | 151 | D | ||||||||||||||
2/11/25 17:00 | 2/7/25 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Patrick W | CA | T | 5 | P.m | 2,446 | 2.06 | 0 | 1,189 | 57 | 3,258 | I | |||||||||||||||
2/10/25 20:43 | 2/6/25 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | Broadwood Partners, L.P. | NY | T | 1 | P.d | 10,590 | 2.05 | 0 | 5,166 | 29 | 22,820 | M | |||||||||||||||
12/26/24 18:17 | 12/26/24 | OCX | Health | Diagn | In Vitro & In Vivo Diagnostic | Arno Andrew | CA | D | 1 | P | 26 | 2.11 | 0 | 13 | 15 | 97 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |